Postmenopausal Meigs’ Syndrome in Elevated CA-125: A Case Report
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Meigs’ syndrome is a benign ovarian tumor associated with ascites and pleural effusion. Elevated cancer antigen 125 (CA-125) in Meigs’ syndrome is an unusual clinical condition reported in few cases. We report here on a 61-year-old woman who presented with dyspnea; in imaging assessment, a heterogeneous pelvic mass measuring 12 × 11 cm with ascitic fluid was reported. Pleural effusion was detected on Chest X-ray. Aspiration of pleural fluid showed no evidence of malignancy. CA-125 level was 347 IU/mL. The patient underwent laparotomy during which a mass measuring 12 × 11 cm was detected in her left adnexa. Histology showed ovarian thecoma. The mass was resected, and, after that, the symptoms disappeared and CA-125 level reached 19 IU/mL. The patient had experienced no problem after 12 months of follow up. Although postmenopausal women with ovarian tumor, ascites, pleural effusion, and elevation of CA-125 levels probably have malignant ovarian tumors, Meigs' syndrome must be considered in the differential diagnosis. (J Menopausal Med 2015;21:56-59)
Abstract
Meigs’ syndrome is a benign ovarian tumor associated with ascites and pleural effusion. Elevated cancer antigen 125 (CA-125) in Meigs’ syndrome is an unusual clinical condition reported in few cases. We report here on a 61-year-old woman who presented with dyspnea; in imaging assessment, a heterogeneous pelvic mass measuring 12 × 11 cm with ascitic fluid was reported. Pleural effusion was detected on Chest X-ray. Aspiration of pleural fluid showed no evidence of malignancy. CA-125 level was 347 IU/mL. The patient underwent laparotomy during which a mass measuring 12 × 11 cm was detected in her left adnexa. Histology showed ovarian thecoma. The mass was resected, and, after that, the symptoms disappeared and CA-125 level reached 19 IU/mL. The patient had experienced no problem after 12 months of follow up. Although postmenopausal women with ovarian tumor, ascites, pleural effusion, and elevation of CA-125 levels probably have malignant ovarian tumors, Meigs' syndrome must be considered in the differential diagnosis. (J Menopausal Med 2015;21:56-59)
참고문헌 (12)
- Parkin DM., "Global cancer statistics, 2002", CA Cancer J Clin, 55, pp.74~108 (2005)
- Meigs JV., "Fibroma of the ovary with ascites and hydrothorax; Meigs' syndrome", Am J Obstet Gynecol, 67, pp.962~985 (1954)
- Benjapibal M., "Meigs' Syndrome with Elevated Serum CA125 : Case Report and Review of the Literature", Case Rep Oncol, 2, pp.61~66 (2009)
- Turan YH., "Elevated CA 125 in Meigs syndrome", Int J Gynaecol Obstet, 43, pp.64~65 (1993)
- Abramov Y., "The role of inflammatory cytokines in Meigs' syndrome", Obstet Gynecol, 99, pp.917~919 (2002)
- Agranoff D., "Pleural effusion and a pelvic mass", Postgrad Med J, 74, pp.265~267 (1998)
- Mui MP., "Coexistence of struma ovarii with marked ascites and elevated CA-125 levels : case report and literature review", Arch Gynecol Obstet, 279, pp.753~757 (2009)
- Bast RC. Jr., "Reactivity of a monoclonal antibody with human ovarian carcinoma", J Clin Invest, 68, pp.1331~1337 (1981)
- Kabawat SE., "Tissue distribution of a coelomic-epitheliumrelated antigen recognized by the monoclonal antibody OC125", Int J Gynecol Pathol, 2, pp.275~285 (1983)
- Jacobs I., "The CA 125 tumour-associated antigen : a review of the literature", Hum Reprod, 4, pp.1~12 (1989)
- Kudlacek S., "Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer", Gynecol Oncol, 35, pp.323~329 (1989)
- O'Connell GJ., "Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses", Obstet Gynecol, 70, pp.930~932 (1987)